Nifty
:
16148.50
Sensex
:
54145.78
-66.20 (-0.41%)
-142.83 (-0.26%)
Nifty
Sensex
:
:
16148.50
54145.78
-66.20 (-0.41%)
-142.83 (-0.26%)

Wockhardt Ltd.

Pharmaceuticals & Drugs - Global

Rating :
39/99

BSE: 532300 | NSE: WOCKPHARMA

NSE BSE
281.75
23-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  272.00
  •  291.65
  •  268.20
  •  271.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1440738
  •  4079.24
  •  741.98
  •  228.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,055.29
  • N/A
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,095.23
  • N/A
  • 0.98

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.13%
  • 2.35%
  • 24.56%
  • FII
  • DII
  • Others
  • 2.89%
  • 0.03%
  • 3.04%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.44
  • -7.21
  • -12.75

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.64
  • 34.04
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.36
  • 1.74
  • 1.35

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 56.73
  • 78.79
  • 40.57

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
853.89
764.02
11.76%
862.00
714.05
20.72%
859.55
598.27
43.67%
631.96
686.93
-8.00%
Expenses
742.44
708.23
4.83%
766.17
697.35
9.87%
752.01
670.32
12.19%
712.22
680.92
4.60%
EBITDA
111.45
55.79
99.77%
95.83
16.70
473.83%
107.54
-72.05
-
-80.26
6.01
-
EBIDTM
13.05%
7.30%
11.12%
2.34%
12.51%
-12.04%
-12.70%
0.87%
Other Income
2.05
103.13
-98.01%
5.20
16.24
-67.98%
14.90
7.95
87.42%
21.74
21.17
2.69%
Interest
80.08
59.85
33.80%
69.06
60.90
13.40%
64.10
73.70
-13.03%
54.63
61.44
-11.08%
Depreciation
61.98
67.88
-8.69%
61.21
57.15
7.10%
64.34
55.96
14.97%
65.03
60.87
6.83%
PBT
-28.56
31.19
-
-29.24
-85.11
-
-6.00
-336.24
-
-178.18
-95.13
-
Tax
-30.33
-1.21
-
-66.41
-88.40
-
0.58
-110.66
-
-71.34
-143.86
-
PAT
1.77
32.40
-94.54%
37.17
3.29
1,029.79%
-6.58
-225.58
-
-106.84
48.73
-
PATM
0.21%
4.24%
4.31%
0.46%
-0.77%
-37.71%
-16.91%
7.09%
EPS
-0.56
1.27
-
2.79
0.30
830.00%
-1.06
63.25
-
-7.72
4.02
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
3,207.40
2,762.04
3,325.15
4,158.38
3,936.90
4,014.61
4,453.22
4,481.54
4,830.36
5,609.42
4,350.50
Net Sales Growth
16.07%
-16.93%
-20.04%
5.63%
-1.94%
-9.85%
-0.63%
-7.22%
-13.89%
28.94%
 
Cost Of Goods Sold
1,301.54
1,135.49
1,203.45
1,636.31
1,797.53
1,662.07
1,613.68
1,487.48
1,806.25
1,747.56
1,534.38
Gross Profit
1,905.86
1,626.55
2,121.70
2,522.07
2,139.37
2,352.54
2,839.54
2,994.06
3,024.11
3,861.86
2,816.12
GP Margin
59.42%
58.89%
63.81%
60.65%
54.34%
58.60%
63.76%
66.81%
62.61%
68.85%
64.73%
Total Expenditure
2,972.84
2,832.36
3,082.03
4,050.63
3,935.07
3,988.39
3,958.98
3,772.14
3,804.65
3,549.74
2,996.79
Power & Fuel Cost
-
82.37
85.41
93.30
77.80
110.10
113.99
101.40
92.17
97.08
80.38
% Of Sales
-
2.98%
2.57%
2.24%
1.98%
2.74%
2.56%
2.26%
1.91%
1.73%
1.85%
Employee Cost
-
762.95
743.33
800.38
937.06
966.51
950.77
868.87
768.63
655.90
572.91
% Of Sales
-
27.62%
22.35%
19.25%
23.80%
24.07%
21.35%
19.39%
15.91%
11.69%
13.17%
Manufacturing Exp.
-
151.85
120.90
153.76
135.27
179.40
228.07
236.03
240.85
180.06
115.03
% Of Sales
-
5.50%
3.64%
3.70%
3.44%
4.47%
5.12%
5.27%
4.99%
3.21%
2.64%
General & Admin Exp.
-
251.33
186.55
380.13
476.66
504.43
405.85
320.92
352.19
248.28
194.47
% Of Sales
-
9.10%
5.61%
9.14%
12.11%
12.56%
9.11%
7.16%
7.29%
4.43%
4.47%
Selling & Distn. Exp.
-
131.62
141.18
176.22
208.89
205.30
241.11
261.55
292.98
291.74
214.75
% Of Sales
-
4.77%
4.25%
4.24%
5.31%
5.11%
5.41%
5.84%
6.07%
5.20%
4.94%
Miscellaneous Exp.
-
316.75
601.21
810.53
301.86
360.58
405.51
495.89
251.58
329.12
214.75
% Of Sales
-
11.47%
18.08%
19.49%
7.67%
8.98%
9.11%
11.07%
5.21%
5.87%
6.55%
EBITDA
234.56
-70.32
243.12
107.75
1.83
26.22
494.24
709.40
1,025.71
2,059.68
1,353.71
EBITDA Margin
7.31%
-2.55%
7.31%
2.59%
0.05%
0.65%
11.10%
15.83%
21.23%
36.72%
31.12%
Other Income
43.89
153.43
60.08
21.02
120.23
100.83
66.10
66.55
38.40
54.00
25.34
Interest
267.87
249.08
275.74
265.14
255.49
225.27
128.96
55.21
83.35
215.37
269.02
Depreciation
252.56
246.02
224.14
163.95
149.53
148.93
141.91
145.40
139.92
122.14
115.07
PBT
-241.98
-411.99
-196.68
-300.32
-282.96
-247.15
289.47
575.34
840.84
1,776.17
994.96
Tax
-167.50
227.25
-153.29
-83.66
25.70
-21.11
37.88
162.65
47.88
258.21
221.74
Tax Rate
69.22%
24.81%
77.94%
27.86%
-4.01%
8.54%
13.09%
28.27%
5.38%
14.05%
42.54%
PAT
-74.48
686.06
-69.22
-194.53
-608.30
-195.72
250.08
404.91
840.72
1,579.48
299.45
PAT before Minority Interest
-78.75
688.60
-43.39
-216.66
-666.85
-226.04
251.59
412.69
842.79
1,579.48
299.45
Minority Interest
-4.27
-2.54
-25.83
22.13
58.55
30.32
-1.51
-7.78
-2.07
0.00
0.00
PAT Margin
-2.32%
24.84%
-2.08%
-4.68%
-15.45%
-4.88%
5.62%
9.04%
17.40%
28.16%
6.88%
PAT Growth
0.00%
-
-
-
-
-
-38.24%
-51.84%
-46.77%
427.46%
 
EPS
-5.17
47.61
-4.80
-13.50
-42.21
-13.58
17.35
28.10
58.34
109.61
20.78

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
3,376.76
2,671.67
2,674.80
2,852.15
3,336.71
3,775.12
3,715.35
3,581.47
2,704.18
1,471.02
Share Capital
55.39
55.37
55.34
55.32
55.27
55.25
353.59
353.43
353.34
816.09
Total Reserves
3,293.85
2,586.33
2,587.19
2,760.11
3,244.43
3,691.22
3,315.65
3,182.73
2,319.30
644.73
Non-Current Liabilities
496.72
1,194.85
1,702.75
2,088.89
3,151.38
1,893.49
1,872.46
1,161.18
1,520.80
2,891.88
Secured Loans
500.19
1,237.44
1,653.25
2,167.84
2,887.11
1,647.34
1,180.25
1,096.27
1,467.51
2,697.34
Unsecured Loans
2.66
3.46
238.22
5.27
303.16
273.26
4.59
6.03
7.64
9.05
Long Term Provisions
84.37
45.60
53.48
64.89
94.23
70.74
635.05
51.98
69.85
84.49
Current Liabilities
3,118.22
3,497.18
2,863.66
2,691.71
1,978.81
1,841.85
1,772.97
1,743.20
1,773.48
1,890.94
Trade Payables
577.97
895.27
840.24
601.78
533.81
637.69
552.56
557.79
634.15
540.80
Other Current Liabilities
1,345.49
1,579.80
1,353.09
1,548.13
690.13
621.23
844.44
947.70
789.96
978.38
Short Term Borrowings
1,066.11
903.86
561.71
437.09
662.80
550.03
348.28
210.20
182.00
260.80
Short Term Provisions
128.65
118.25
108.62
104.71
92.07
32.90
27.69
27.51
167.37
110.96
Total Liabilities
7,375.19
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46
6,253.84
Net Block
3,343.12
3,502.29
3,057.93
2,887.96
2,772.55
2,808.70
2,122.74
2,294.63
1,989.60
2,571.34
Gross Block
5,655.58
6,703.28
6,112.89
5,772.29
5,456.40
4,377.01
4,552.96
4,642.81
4,295.75
4,211.60
Accumulated Depreciation
2,312.46
3,200.99
3,054.96
2,884.33
2,683.85
1,568.31
2,430.22
2,348.18
1,684.94
1,306.76
Non Current Assets
4,950.81
5,319.66
4,756.39
4,598.88
4,313.57
4,023.94
3,983.17
3,266.10
2,671.53
3,772.33
Capital Work in Progress
1,378.94
1,584.53
1,445.48
1,432.57
1,243.95
1,036.05
1,007.30
707.53
490.94
902.29
Non Current Investment
0.45
0.45
0.45
0.45
0.45
0.45
2.62
2.62
2.63
90.75
Long Term Loans & Adv.
227.36
230.63
252.37
277.90
296.62
178.74
845.68
235.86
183.35
207.95
Other Non Current Assets
0.94
1.76
0.16
0.00
0.00
0.00
4.83
25.46
5.01
0.00
Current Assets
2,424.38
2,429.83
2,814.65
3,379.60
4,535.27
3,951.85
3,521.56
3,355.92
3,326.93
2,481.51
Current Investments
0.00
0.00
0.00
213.25
562.27
0.00
338.72
573.98
0.00
0.00
Inventories
798.88
689.83
819.36
855.71
1,107.95
1,102.16
1,020.78
992.89
1,058.83
888.56
Sundry Debtors
917.65
1,242.69
1,273.90
962.45
1,034.45
1,111.42
741.43
481.04
958.46
758.69
Cash & Bank
291.79
268.46
448.65
1,082.25
1,603.61
1,478.11
1,234.55
1,125.80
1,096.06
699.99
Other Current Assets
416.06
56.64
20.18
8.31
226.99
260.16
186.08
182.21
213.58
134.27
Short Term Loans & Adv.
271.77
172.21
252.56
257.63
197.75
260.16
186.08
182.21
213.58
134.27
Net Current Assets
-693.84
-1,067.35
-49.01
687.89
2,556.46
2,110.00
1,748.59
1,612.72
1,553.45
590.57
Total Assets
7,375.19
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46
6,253.84

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
-287.32
648.96
183.32
68.44
-269.47
71.61
354.96
1,476.29
1,532.40
1,343.83
PBT
915.85
-196.68
-300.32
-641.15
-247.15
357.01
575.34
890.67
1,860.20
576.72
Adjustment
-942.27
483.23
444.52
448.78
303.04
201.29
285.63
133.53
273.31
917.59
Changes in Working Capital
-143.59
379.58
80.29
278.33
-297.39
-402.76
-344.62
587.99
-266.99
-129.94
Cash after chg. in Working capital
-170.01
666.13
224.49
85.96
-241.50
155.54
516.35
1,612.19
1,866.52
1,364.37
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-117.31
-17.17
-41.17
-17.52
-27.97
-83.93
-161.39
-135.90
-334.12
-20.54
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
1,470.10
-155.53
94.57
630.24
-686.64
-818.19
-206.63
-851.62
1,085.37
-305.45
Net Fixed Assets
-199.82
-499.84
-39.00
-45.55
-166.75
-368.17
-299.87
-283.99
174.15
-181.64
Net Investments
0.00
0.00
-0.05
0.00
0.00
0.00
10.73
0.00
0.00
0.00
Others
1,669.92
344.31
133.62
675.79
-519.89
-450.02
82.51
-567.63
911.22
-123.81
Cash from Financing Activity
-1,170.82
-679.58
-776.45
-769.47
1,254.49
254.26
-75.65
-601.32
-2,245.75
-826.56
Net Cash Inflow / Outflow
11.96
-186.15
-498.56
-70.79
298.38
-492.32
72.68
23.35
372.02
211.82
Opening Cash & Equivalents
219.34
397.34
897.24
963.64
662.98
1,158.69
1,101.65
1,050.01
689.66
470.10
Closing Cash & Equivalent
232.25
219.34
397.34
897.24
963.64
664.64
1,158.69
1,101.65
1,050.01
689.66

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
278.61
238.55
238.75
254.47
298.51
339.05
306.20
294.97
216.65
63.91
ROA
9.11%
-0.57%
-2.79%
-7.93%
-2.69%
3.25%
6.09%
13.36%
25.78%
4.97%
ROE
22.99%
-1.64%
-7.94%
-21.81%
-6.42%
7.07%
12.49%
30.04%
102.78%
66.74%
ROCE
20.10%
1.32%
-0.56%
-5.47%
-0.31%
6.87%
11.25%
18.98%
43.10%
17.39%
Fixed Asset Turnover
0.45
0.52
0.70
0.70
0.82
1.00
0.98
1.08
1.32
1.05
Receivable days
142.74
138.12
98.15
92.57
97.55
75.93
49.71
54.33
55.81
57.17
Inventory Days
98.37
82.83
73.51
91.03
100.47
87.00
81.88
77.43
63.29
67.16
Payable days
236.78
129.66
86.65
67.29
64.08
64.54
63.71
65.00
65.49
65.74
Cash Conversion Cycle
4.32
91.29
85.01
116.31
133.94
98.39
67.88
66.75
53.61
58.58
Total Debt/Equity
0.70
1.22
1.28
1.33
1.26
0.71
0.55
0.54
0.77
2.25
Interest Cover
4.68
0.29
-0.13
-1.51
-0.10
3.24
11.42
11.69
9.53
2.94

Annual Reports:

FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012

News Update:


  • Wockhardt’s arm collaborates with Serum Life Sciences UK for manufacturing multiple vaccines in UK
    21st Mar 2022, 09:48 AM

    This collaboration between a subsidiary of Wockhardt and Serum Life Sciences UK will help create considerable number of employment opportunities

    Read More
  • NIH to conduct human Phase 1 trial of Wockhardt’s WCK 6777
    16th Mar 2022, 10:22 AM

    The trial will be conducted at NIAID’s Phase I clinical trial units in the USA

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.